SUSANNE KLATTEN

Susanne Klatten was born in 1962 as Susanne Quandt, daughter of Herbert Quandt, the man who saved BMW from bankruptcy in 1959. When Herbert restructured BMW and invested his own money to keep the company alive, he secured the Quandt family's controlling stake.

That decision would eventually make his children among the richest people in Europe.

Klatten studied economics and business administration. She also worked under a fake name at a BMW plant and at a management consultancy to learn business without the Quandt name opening doors.

She used her mother's maiden name, calling herself Susanne Kant.

When her father died in 1982, she inherited a stake in BMW. When her mother Johanna Quandt died in 2015, Susanne's share grew to 19.1%.

Her brother Stefan Quandt holds 25.6%. Together they control BMW.

But Klatten didn't just sit on the inheritance. In 2002, she took full control of Altana, a pharmaceutical and chemical company her family had invested in.

She sold Altana's pharma division to Nycomed for $5.6 billion in 2006, a brilliant move that unlocked massive value. She kept the specialty chemicals division, which she built into a global leader.

She's also made venture investments through her fund UnternehmerTUM, one of Europe's largest entrepreneurship centers, based in Munich. She's backed clean energy startups, biotech companies, and technology firms.

BMW is the big one. Her 19.1% stake makes her one of the largest individual shareholders of any major automaker in the world.

BMW includes Rolls-Royce, Mini, and BMW Motorrad. The company does about $155 billion in annual revenue.

Altana AG is her personal project. After selling the pharma business, she refocused the company entirely on specialty chemicals.

Altana now makes coatings, adhesives, and sealants used in everything from smartphones to cars. Revenue is about $3.5 billion annually.

It's consistently profitable and mostly flies under the radar.

SHE Ventures is her investment vehicle for technology startups. She's invested in carbon capture, renewable energy, and deep tech companies.

UnternehmerTUM, which she co-founded and funds, has incubated hundreds of startups from Technical University of Munich.

Klatten is a patient, controlling investor. She doesn't flip assets.

She buys things, improves them, and holds them. The Altana transformation is the clearest example.

She bought out minority shareholders, sold the less valuable division at a great price, and invested in the division with better long-term economics.

In public markets, she holds her BMW stake through good times and bad. During the 2008 financial crisis, when BMW's stock dropped over 60%, she didn't sell a single share.

Same during the diesel emissions scandal. Same during COVID.

Her venture investments are strategic, not financial. She backs founders working on problems that matter to her personally, particularly sustainability and advanced manufacturing.

The Altana pharma sale in 2006. Klatten sold Altana's pharmaceutical business to Nycomed for $5.6 billion.

The timing was perfect. The pharma unit's key drug, Pantoprazole, was approaching patent expiration, which would have crushed its value within a few years.

She got top dollar for an asset with a declining future and reinvested the proceeds into Altana's chemical division, which had better margins and less patent risk. The chemical business has since tripled in revenue.

The BMW stake itself is arguably the biggest win, but she didn't make that bet. Her father did.

What she did was refuse to sell during every crisis, which compounded the family's wealth over decades.

The Helg Sgarbi affair in 2008. Klatten entered a relationship with Sgarbi, a Swiss-Italian gigolo who secretly filmed their encounters and then blackmailed her for $67 million.

Instead of paying, Klatten went to the police. Sgarbi was sentenced to six years in prison.

The incident was humiliating and dominated German tabloids for months. It exposed Klatten to the kind of public scrutiny she had spent her entire life avoiding.

But her decision to go to the police rather than pay was widely admired. She turned a personal crisis into a moment that actually enhanced her reputation for toughness.

On the business side, her biggest misstep was arguably moving too slowly on electric vehicles at BMW. The company had an early lead with the i3 in 2013 but then pulled back, letting Tesla and Chinese EV makers grab market share.

Klatten believes in active ownership. She doesn't just own shares.

She sits on boards, pushes strategy, and holds management accountable. Her involvement in Altana's transformation is proof that she's not a passive heir.

She also believes in keeping things private. Altana has been delisted from public markets since 2007.

Klatten prefers the freedom to make long-term decisions without quarterly earnings pressure.

Patience is central. She once said that the biggest advantage of family-owned wealth is the ability to think in generations rather than quarters.

BMW's EV transition, which is costing billions, is easier to stomach when the controlling family isn't worried about next quarter's stock price.

Susanne married Jan Klatten, an engineer, in 1990. They have three children.

The family lives in Munich and keeps an extremely low profile.

Her brother Stefan Quandt holds the larger BMW stake (25.6%) and is also intensely private. Together they control the company their father saved from bankruptcy in 1959.

The Quandt family history has a dark chapter. During World War II, Susanne's grandfather Guenther Quandt and great-uncle Harald Quandt were members of the Nazi Party.

Their companies used forced labor. A 2007 documentary brought this history into public view.

The family commissioned an independent historical study of the Quandt business activities during the war, which confirmed the use of forced labor.

Klatten studied economics and business administration at the University of Buckingham in England and later earned an MBA from IMD in Lausanne, Switzerland. She also worked incognito at a BMW factory and at the consulting firm McKinsey before revealing her identity.

The McKinsey experience, in particular, gave her the analytical framework she later applied to restructuring Altana. She approached the pharma sale with the precision of a consultant, not the sentimentality of an heir.

As an Amazon Associate, Netfigo earns from qualifying purchases. Book links above may be affiliate links.